Presenile cataract: Consider cholestanol

Archives of Ophthalmology

Volumn 124, Issue 10, 2006, Pages 1490-1492

  Tészás, Alexandra ^b   Pfund, Zoltán ^b   Morava, Éva ^b   Kosztolányi, György ^b   Sistermans, Erik ^b   Wevers, Ron A ^b   Kellermayer, Richard ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTANOL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CATARACT; CLINICAL FEATURE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; KARYOTYPE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; CATARACT; CATARACT EXTRACTION; CHENODEOXYCHOLIC ACID; CHOLESTANOL; CHOLESTANOLS; CYTOCHROME P-450 CYP27A1; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MUTATION; STEROID HYDROXYLASES; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 33749558984     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.10.1490     Document Type: Article

References (5)

1. Forsius H, Arentz-Grastvedt B, Eriksson AW. Juvenile cataract with autosomal recessive inheritance: a study from the Aland Islands, Finland. Acta Ophthalmol (Copenh). 1992;70:26-32.
2. Verrips A, van Engelen BG, Wevers RA, et al. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol. 2000;57:520-524.
3. Lorincz MT, Rainier S, Thomas D, Fink JK. Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol. 2005;62:1459-1463.
4. Batta AK, Salen G, Tint GS. Hydrophilic 7 betahydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis. Metabolism. 2004;53:556-562.
5. van Heijst AF, Verrips A, Wevers RA, Cruysberg JR, Renier WO, Tolboom JJ. Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr. 1998;157:313-316.